Senior Associate Director, External Relations And Science Communications
Melissa Fassbender is the senior associate director of external relations and science communications at the University of Chicago’s Polsky Center for Entrepreneurship and Innovation. She focuses on highlighting translational research and IP-based startups, while engaging with the entrepreneurial, science, technology, and business communities. Melissa has been featured in the University of Chicago for her work in the fields of technology and deep tech.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Chicago, United States (Local)
Not enough data
Not enough data
Melissa Fassbender's coverage is heavily focused on local business, healthcare, and technology developments in the Chicago area. She regularly covers industry-specific news and press releases related to startups, innovation programs, and advancements in healthcare and technology.
Given Melissa’s focus on local events and organizations such as the University of Chicago and Polsky Center, she may be receptive to pitches that involve local businesses or experts with insights into the Chicago-area startup scene. Additionally, sources with expertise in data science, AI startups, life sciences innovation, or other technological advancements are likely to resonate well with her coverage.
It would also be beneficial for potential sources to provide expert commentary on emerging technologies or innovative trends within the specified industries covered by Melissa.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Melissa Fassbender
The University of Chicago this week celebrated the opening of Hyde Park Labs and its new UChicago Science Incubator — advancing the University's long-term vision to bring world-class research, entrepreneurial activity, and community impact to Chicago's South Side.
By: Melissa Fassbender
Founded by an interventional cardiologist at the University of Chicago, Parasol has developed a novel, minimally invasive device to reduce the risk of stroke in patients with atrial fibrillation.
Alchemist Accelerator and the University of Chicago's Polsky Center for Entrepreneurship and Innovation are thrilled to announce the inaugural cohort of Alchemist Chicago.
By: Melissa Fassbender
The new cohort of the Polsky Science and Technology Associates includes three University of Chicago graduate students who are working with the Polsky Center's technology and business development teams to support many aspects of the technology commercialization process.
By: Melissa Fassbender
The spring 2026 George Shultz Innovation Fund finalists are developing novel software, medical devices, and therapeutics.
By: Melissa Fassbender
Cofounded at the University of Chicago, Quantum spin-out memQ has raised $10 million in a Series A round to fuel new stage of growth.
By: Melissa Fassbender
CavilinQ has raised $8.8 million in seed funding to develop scalable quantum computing architecture based on pioneering research at the University of Chicago.
By: Melissa Fassbender
The George Shultz Innovation Fund has selected two University of Chicago startups, Parasol Medtech and Signl, for an investment of $250,000 each.
By: Melissa Fassbender
Kompass Diagnostics is developing a next-generation diagnostic platform based on research at the University of Chicago and has secured an exclusive license as it looks to bring the technology to patients.
By: Melissa Fassbender
Enemsa Pharma has been granted exclusive patent rights from the University of Chicago to use a family of small molecules for the treatment of demyelinating diseases.
